Prevention of pneumococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)
Published Date:April 4, 1997
Corporate Authors:Centers for Disease Control (U.S.). Immunization Practices Advisory Committee. ; Centers for Disease Control and Prevention (U.S.) ; National Center for Infectious Diseases (U.S.), Division of Bacterial and Mycotic Diseases.
Prevention & Control
Pneumococcal Infections/Prevention & Control
Pneumonia, Pneumococcal/Prevention/United States
Series:MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 46, no. RR-8
Description:" This report updates the last recommendations by the Advisory Committee on Immunization Practices (ACIP) concerning pneumococcal polysaccharide vaccine (MMWR 1989;38:64-8,73-6). ACIP recommends that the vaccine be used more extensively and administered to all persons in the following groups: a) persons aged greater than or equal to 65 years, b) immunocompetent persons aged greater than or equal to 2 years who are at increased risk for illness and death associated with pneumococcal disease because of chronic illness, c) persons aged greater than or equal to 2 years with functional or anatomic asplenia, d) persons aged greater than or equal to 2 years living in environments in which the risk for disease is high, and e) immunocompromised persons aged greater than or equal to 2 years who are at high risk for infection. This report contains updated information regarding a) antimicrobial resistance among pneumococci, b) vaccine effectiveness and cost-effectiveness, c) indications for vaccination, d) guidelines for revaccination, e) strategies for improving delivery of vaccine, and f) development of pneumococcal conjugate vaccine." - p. 1
Includes bibliographical references (p. 19-24).
Supporting Files:No Additional Files
You May Also Like: